📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Human USP18 protects diverse cancer lineages from Type I Interferon independently of its canonical catalytic function (2023)

First Author: Jové V

Attributed to: Substrate Peptidomimetic Inhibitors (SPIs) of the COP9 signalosome funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2023.03.23.533924

Publication URI: http://dx.doi.org/10.1101/2023.03.23.533924

Type: Preprint